FDA Improvement Act Introduced In House

Law360, New York (May 15, 2007, 12:00 AM EDT) -- Legislation has been introduced into the U.S. House of Representatives that would bar the U.S. Food and Drug Administration from collecting drug user fees that manufacturers pay to seek the agency’s approval for their products.

Rep. Maurice Hinchey (D.-N.Y.) on May 10 introduced H. R. 2273, or the Food and Drug Administration Improvement Act of 2007 (FDAIA), saying it would “end the inappropriately close relationship between the drug industry and the FDA.”

The bill would prohibit the agency from collecting fees paid by the drug and...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.